Skip to main content
PMC home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1993 Apr 25;21(8):1827–1835. doi: 10.1093/nar/21.8.1827

Mutagenesis of the cyclic AMP receptor protein of Escherichia coli: targeting positions 72 and 82 of the cyclic nucleotide binding pocket.

A O Belduz 1, E J Lee 1, J G Harman 1
PMCID: PMC309421  PMID: 8388097

Abstract

The 3', 5' cyclic adenosine monophosphate (cAMP) binding pocket of the cAMP receptor protein (CRP) of Escherichia coli was mutagenized to substitute leucine, glutamine, or aspartate for glutamate 72; and lysine, histidine, leucine, isoleucine, or glutamine for arginine 82. Substitutions were made in wild-type CRP and in a CRP*, or cAMP-independent, form of the protein to assess the effects of the amino acid substitutions on CRP structure. Cells containing the binding pocket residue-substituted forms of CRP were characterized through beta-galactosidase activity and by measurement of cAMP binding activity. This study confirms a role for both glutamate 72 and arginine 82 in cAMP binding and activation of CRP. Glutamine or leucine substitution of glutamate 72 produced forms of CRP having low affinity for the cAMP and unresponsive to the nucleotide. Aspartate substituted for glutamate 72 produced a low affinity cAMP-responsive form of CRP. CRP has a stringent requirement for the positioning of the position 72 glutamate carboxyl group within the cyclic nucleotide binding pocket. Results of this study also indicate that there are differences in the binding requirements of cAMP and cGMP, a competitive inhibitor of cAMP binding to CRP.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiba H., Nakamura T., Mitani H., Mori H. Mutations that alter the allosteric nature of cAMP receptor protein of Escherichia coli. EMBO J. 1985 Dec 1;4(12):3329–3332. doi: 10.1002/j.1460-2075.1985.tb04084.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson W. B., Perlman R. L., Pastan I. Effect of adenosine 3',5'-monophosphate analogues on the activity of the cyclic adenosine 3',5'-monophosphate receptor in Escherichia coli. J Biol Chem. 1972 May 10;247(9):2717–2722. [PubMed] [Google Scholar]
  3. Bernard H. U., Helinski D. R. Use of the lambda phage promoter PL to promote gene expression in hybrid plasmid cloning vehicles. Methods Enzymol. 1979;68:482–492. doi: 10.1016/0076-6879(79)68037-0. [DOI] [PubMed] [Google Scholar]
  4. Botsford J. L., Harman J. G. Cyclic AMP in prokaryotes. Microbiol Rev. 1992 Mar;56(1):100–122. doi: 10.1128/mr.56.1.100-122.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  6. Bubis J., Neitzel J. J., Saraswat L. D., Taylor S. S. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase. J Biol Chem. 1988 Jul 15;263(20):9668–9673. [PubMed] [Google Scholar]
  7. Carter P., Bedouelle H., Winter G. Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nucleic Acids Res. 1985 Jun 25;13(12):4431–4443. doi: 10.1093/nar/13.12.4431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ebright R. H., Le Grice S. F., Miller J. P., Krakow J. S. Analogs of cyclic AMP that elicit the biochemically defined conformational change in catabolite gene activator protein (CAP) but do not stimulate binding to DNA. J Mol Biol. 1985 Mar 5;182(1):91–107. doi: 10.1016/0022-2836(85)90030-0. [DOI] [PubMed] [Google Scholar]
  9. Emmer M., deCrombrugghe B., Pastan I., Perlman R. Cyclic AMP receptor protein of E. coli: its role in the synthesis of inducible enzymes. Proc Natl Acad Sci U S A. 1970 Jun;66(2):480–487. doi: 10.1073/pnas.66.2.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Epstein W., Rothman-Denes L. B., Hesse J. Adenosine 3':5'-cyclic monophosphate as mediator of catabolite repression in Escherichia coli. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2300–2304. doi: 10.1073/pnas.72.6.2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eschenlauer A. C., Reznikoff W. S. Escherichia coli catabolite gene activator protein mutants defective in positive control of lac operon transcription. J Bacteriol. 1991 Aug;173(16):5024–5029. doi: 10.1128/jb.173.16.5024-5029.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garges S., Adhya S. Sites of allosteric shift in the structure of the cyclic AMP receptor protein. Cell. 1985 Jul;41(3):745–751. doi: 10.1016/s0092-8674(85)80055-6. [DOI] [PubMed] [Google Scholar]
  13. Gronenborn A. M., Sandulache R., Gärtner S., Clore G. M. Mutations in the cyclic AMP binding site of the cyclic AMP receptor protein of Escherichia coli. Biochem J. 1988 Aug 1;253(3):801–807. doi: 10.1042/bj2530801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harman J. G., Dobrogosz W. J. Mechanism of CRP-mediated cya suppression in Escherichia coli. J Bacteriol. 1983 Jan;153(1):191–199. doi: 10.1128/jb.153.1.191-199.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harman J. G., McKenney K., Peterkofsky A. Structure-function analysis of three cAMP-independent forms of the cAMP receptor protein. J Biol Chem. 1986 Dec 15;261(35):16332–16339. [PubMed] [Google Scholar]
  16. Harman J. G., Peterkofsky A., McKenney K. Arginine substituted for leucine at position 195 produces a cyclic AMP-independent form of the Escherichia coli cyclic AMP receptor protein. J Biol Chem. 1988 Jun 15;263(17):8072–8077. [PubMed] [Google Scholar]
  17. Heyduk T., Lee J. C. Escherichia coli cAMP receptor protein: evidence for three protein conformational states with different promoter binding affinities. Biochemistry. 1989 Aug 22;28(17):6914–6924. doi: 10.1021/bi00443a021. [DOI] [PubMed] [Google Scholar]
  18. Hudson J. M., Fried M. G. Co-operative interactions between the catabolite gene activator protein and the lac repressor at the lactose promoter. J Mol Biol. 1990 Jul 20;214(2):381–396. doi: 10.1016/0022-2836(90)90188-R. [DOI] [PubMed] [Google Scholar]
  19. Kim J., Adhya S., Garges S. Allosteric changes in the cAMP receptor protein of Escherichia coli: hinge reorientation. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9700–9704. doi: 10.1073/pnas.89.20.9700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Krakow J. S. Cyclic adenosine monophosphate receptor: effect of cyclic AMP analogues on DNA binding and proteolytic inactivation. Biochim Biophys Acta. 1975 Apr 2;383(4):345–350. doi: 10.1016/0005-2787(75)90303-2. [DOI] [PubMed] [Google Scholar]
  21. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kypr J., Mrázek J. Possible mechanism of the allosteric activation of cAMP receptor protein. Biochem Biophys Res Commun. 1985 Sep 16;131(2):780–785. doi: 10.1016/0006-291x(85)91307-5. [DOI] [PubMed] [Google Scholar]
  23. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  24. McKay D. B., Steitz T. A. Structure of catabolite gene activator protein at 2.9 A resolution suggests binding to left-handed B-DNA. Nature. 1981 Apr 30;290(5809):744–749. doi: 10.1038/290744a0. [DOI] [PubMed] [Google Scholar]
  25. Moore J., Kantorow M., Vanderzwaag D., McKenney K. Escherichia coli cyclic AMP receptor protein mutants provide evidence for ligand contacts important in activation. J Bacteriol. 1992 Dec;174(24):8030–8035. doi: 10.1128/jb.174.24.8030-8035.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ogreid D., Døskeland S. O., Gorman K. B., Steinberg R. A. Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase. J Biol Chem. 1988 Nov 25;263(33):17397–17404. [PubMed] [Google Scholar]
  27. Puskas R., Fredd N., Gazdar C., Peterkofsky A. Methylglyoxal-mediated growth inhibition in an Escherichia coli cAMP receptor protein mutant. Arch Biochem Biophys. 1983 Jun;223(2):503–513. doi: 10.1016/0003-9861(83)90615-x. [DOI] [PubMed] [Google Scholar]
  28. Reddy P., Peterkofsky A., McKenney K. Hyperexpression and purification of Escherichia coli adenylate cyclase using a vector designed for expression of lethal gene products. Nucleic Acids Res. 1989 Dec 25;17(24):10473–10488. doi: 10.1093/nar/17.24.10473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ren Y. L., Garges S., Adhya S., Krakow J. S. Characterization of the binding of cAMP and cGMP to the CRP*598 mutant of the E. coli cAMP receptor protein. Nucleic Acids Res. 1990 Sep 11;18(17):5127–5132. doi: 10.1093/nar/18.17.5127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Santa-Coloma T. A., Rossi R. J., Charreau E. H. Solid-phase assay for determination of binding parameters of ligand-protein complexes with high dissociation rates. Anal Biochem. 1991 Feb 1;192(2):367–371. doi: 10.1016/0003-2697(91)90550-d. [DOI] [PubMed] [Google Scholar]
  31. Scholübbers H. G., van Knippenberg P. H., Baraniak J., Stec W. J., Morr M., Jastorff B. Investigations on stimulation of lac transcription in vivo in Escherichia coli by cAMP analogues. Biological activities and structure-activity correlations. Eur J Biochem. 1984 Jan 2;138(1):101–109. doi: 10.1111/j.1432-1033.1984.tb07887.x. [DOI] [PubMed] [Google Scholar]
  32. Shanblatt S. H., Revzin A. Two catabolite activator protein molecules bind to the galactose promoter region of Escherichia coli in the presence of RNA polymerase. Proc Natl Acad Sci U S A. 1983 Mar;80(6):1594–1598. doi: 10.1073/pnas.80.6.1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Takahashi M., Blazy B., Baudras A., Hillen W. Ligand-modulated binding of a gene regulatory protein to DNA. Quantitative analysis of cyclic-AMP induced binding of CRP from Escherichia coli to non-specific and specific DNA targets. J Mol Biol. 1989 Jun 20;207(4):783–796. doi: 10.1016/0022-2836(89)90244-1. [DOI] [PubMed] [Google Scholar]
  34. Weber I. T., Steitz T. A. Structure of a complex of catabolite gene activator protein and cyclic AMP refined at 2.5 A resolution. J Mol Biol. 1987 Nov 20;198(2):311–326. doi: 10.1016/0022-2836(87)90315-9. [DOI] [PubMed] [Google Scholar]
  35. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985;33(1):103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  36. de Crombrugghe B., Busby S., Buc H. Cyclic AMP receptor protein: role in transcription activation. Science. 1984 May 25;224(4651):831–838. doi: 10.1126/science.6372090. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES